|
|
Mission
Over the past several decades, the number of new drugs and therapeutic agents has increased exponentially. This increase has been particularly prevalent with the creation of recombinatorial chemistry libraries and high-throughput screening methods. Yet one of the challenges still facing the therapeutic application of these drugs is their appropriate delivery at the right concentration, in the desired temporal or spatial manner, etc. The same can be said for tissue engineering; namely that we know what cells we would like to use, but effectively getting them where they need to go is still a challenge.
Our research group is examining the creation of novel polymeric platforms for drug delivery and tissue engineering, focusing on the use of molecular interactions - affinity - to control drug delivery rate, generating devices which can be reloaded in vivo for multiple therapeutic windows or loaded with drug only as needed. Our work has been applied toward a number of therapeutic applications including cancer, cardiovascular disease, HIV, implant infection, and wound healing.
Our research group is examining the creation of novel polymeric platforms for drug delivery and tissue engineering, focusing on the use of molecular interactions - affinity - to control drug delivery rate, generating devices which can be reloaded in vivo for multiple therapeutic windows or loaded with drug only as needed. Our work has been applied toward a number of therapeutic applications including cancer, cardiovascular disease, HIV, implant infection, and wound healing.
|
|
